The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Roche Pharma AG
Stock and Other Ownership Interests - Roche Pharma AG
GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma.
 
Laurie Helen Sehn
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen; Lundbeck; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; Celgene; Gilead Sciences; Janssen; Lundbeck; Pfizer; Roche/Genentech
Research Funding - Roche Pharma AG (Inst)
 
Neil Sun Chua
Consulting or Advisory Role - Seagen
Research Funding - Roche Pharma AG (Inst)
 
Jiri Mayer
Research Funding - Roche Pharma AG (Inst)
 
Gregory Scott Dueck
Honoraria - Celgene; Lundbeck
Research Funding - Celgene (Inst); Lundbeck (Inst); Onyx (Inst); Roche Pharma AG (Inst)
 
Marek Trněný
Honoraria - Celgene; Roche Pharma AG
Consulting or Advisory Role - Celgene; Roche Pharma AG
Research Funding - Celgene (Inst); Roche Pharma AG (Inst)
 
Kamal Bouabdallah
No Relationships to Disclose
 
Nathan Hale Fowler
Consulting or Advisory Role - Celgene; Gilead Sciences; Pharmacyclics; Roche Pharma AG
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Roche Pharma AG (Inst)
 
Vincent Delwail
No Relationships to Disclose
 
Oliver W. Press
Stock and Other Ownership Interests - Emergent Biosolutions; PhaseRx
Consulting or Advisory Role - Adaptive Biotechnologies; Algeta ASA; BIND Biosciences; Roche
Research Funding - Genentech (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Algeta ASA; Roche
 
Gilles A. Salles
Honoraria - Amgen; Mundipharma; Roche/Genentech; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Mundipharma; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
John G. Gribben
Honoraria - Celgene; Gilead Sciences; Janssen; Pharmacyclics; Roche Pharma AG
Travel, Accommodations, Expenses - Gilead Sciences
 
Anne Lennard
Leadership - Specialist Medical Services NE
Stock and Other Ownership Interests - Specialist Medical Services NE
Consulting or Advisory Role - Celgene; Roche Pharma AG; Seagen
Research Funding - Celgene; GlaxoSmithKline; Janssen; Millennium; Roche Pharma AG; Seagen; Takeda
Travel, Accommodations, Expenses - Millennium; Roche Pharma AG; Takeda
 
Pieternella J. Lugtenburg
Consulting or Advisory Role - Celgene; Mundipharma; Roche Pharma AG
 
Natalie Franklin
Employment - GlaxoSmithKline; Roche Pharma AG
Stock and Other Ownership Interests - GlaxoSmithKline
 
Elisabeth Wassner Fritsch
Employment - Roche Pharma AG
 
Guenter Fingerle-Rowson
No Relationships to Disclose
 
Bruce D. Cheson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Pharmacyclics; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Ascent Pharmahealth (Inst); Celgene (Inst); Gilead Sciences (Inst); MedImmune (Inst); Pharmacyclics (Inst); Teva (Inst)